ARMP241115C5000
- 0.25
- 0.000.00%
Armata Pharmaceuticals Newsroom
H.C. Wainwright Maintains Armata Pharmaceuticals(ARMP.US) With Buy Rating, Maintains Target Price $7
Armata Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Armata Pharmaceuticals(ARMP.US) With Buy Rating, Maintains Target Price $7
Armata Pharmaceuticals Analyst Ratings
Ladenburg Thalmann Maintains Armata Pharmaceuticals(ARMP.US) With Buy Rating, Maintains Target Price $9
H.C. Wainwright Maintains Armata Pharmaceuticals(ARMP.US) With Buy Rating, Maintains Target Price $7
Buy Rating Affirmed for Armata Pharmaceuticals Amid Positive Earnings and Promising Clinical Progress
Analysts' Top Healthcare Picks: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Armata Pharmaceuticals (ARMP)
Armata Pharmaceuticals Analyst Ratings
Armata Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target
Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Denali Therapeutics (DNLI) and Armata Pharmaceuticals (ARMP)
Buy Rating Affirmed for Armata Pharmaceuticals Amid Progress in Bacteriophage Therapy Development
Armata Pharmaceuticals Analyst Ratings
Buy Rating Affirmed for Armata Pharmaceuticals Amid Clinical Progress and Strategic Growth
Robust Advancements and Strategic Planning: Key Drivers for Armata Pharmaceuticals' Buy Rating
Ladenburg Thalmann & Co. Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)
Armata Pharmaceuticals Analyst Ratings
H.C. Wainwright Remains a Buy on Armata Pharmaceuticals (ARMP)
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target